home / stock / immx / immx news

IMMX News and Press, Immix Biopharma Inc. From 05/09/22

Stock Information
Company Name: Immix Biopharma Inc.
Stock Symbol: IMMX
Market: NASDAQ
Website: immixbio.com
Menu
IMMX IMMX Quote IMMX Short IMMX News IMMX Articles IMMX Message Board
Get IMMX Alerts

News, Short Squeeze, Breakout and More Instantly...
IMMX - Immix Biopharma announces $1M stock buyback program

Immix Biopharma (NASDAQ:IMMX) said it has received Board's approval on Monday to repurchase up to $1M of its common shares. As of Apr. 15, 2022, the company had about 13.9M shares outstanding. "We are confident that with the $24.2 million gross proceeds raised in our recent IPO, ImmixBio is s...
IMMX - Immix Biopharma Announces Share Repurchase Program

LOS ANGELES, May 09, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx) TM targeting oncology and immuno-d...

IMMX - IMTE, MF and SABS among mid-day movers

Gainers: Sunshine Biopharma (SBFM) +132%. Dingdong Limited (DDL) +29%. System1 (SST) +27%. FG Financial Group (FGF) +25%. Missfresh (MF) +21%. BT Brands (BTBD) +20%. Longeveron (LGVN) +18%. Compass Therapeutics (CMPX) +18%. Allego (ALLG) +17%. Nam Tai Property (NTP) +15%. Losers: IMARA (IMRA)...

IMMX - Sunshine Biopharma, Nano-X top healthcare gainers; IMARA, GBS lead losers' pack

Gainers: Sunshine Biopharma (SBFM) +181%. Nano-X Imaging (NNOX) +15%. Arcus Biosciences (RCUS) +13%. Cue Biopharma (CUE) +11%. Dermata Therapeutics (DRMA) +6%. Losers: IMARA (IMRA) -35%. GBS (GBS) -15%. Precipio (PRPO) -13%. Cassava Sciences (SAVA) -10%...
IMMX - ImmixBio Management Discusses Key Milestones, Drug Development Timelines and the IMMX Advantage at IMMX Milestone Day Event Held on April 5, 2022

The IMMX Milestone Day Event is viewable at www.immixbio.com/Apr2022MilestoneDay Management discussed financial position, milestones, and new opportunities presented by current market volatility ImmixBio plans to commence 2 clinical trials in 2022 LOS ANGELES, April 05, 2022...

IMMX - Immix Biopharma, Inc. Announces IMMX Milestone Day to be Held on April 5, 2022

Management plans to discuss current financial position, milestones, and new opportunities presented by current market volatility With $24.2 million gross proceeds from its December 2021 IPO, ImmixBio plans to commence 2 clinical trials in 2022 A photo accompanying this announcem...

IMMX - ImmixBio Initiates GMP Manufacturing of IMX-120, a Biologic for Inflammatory Bowel Disease

IMX-120 utilizes proprietary, humanized antibody fragment to selectively silence disease-causing, overactive inflammatory bowel immune cells ImmixBio anticipates filing an IND for IMX-120 in 2023 The inflammatory bowel disease market is expected to reach $21.4 billion by 2...
IMMX - IceCure Medical, Atossa top healthcare gainers; Dermata, Statera among losers

Gainers: IceCure Medical (NASDAQ:ICCM) +16%. Atossa Therapeutics (NASDAQ:ATOS) +15%. G Medical Innovations (NASDAQ:GMVD) +11%. Exscientia (NASDAQ:EXAI) +10%. Immix Biopharma (NASDAQ:IMMX) +10%. Losers: Dermata Therapeutics (NASDAQ:DRMA) -...

IMMX - RIOT, MARA and MNKD among pre market gainers

Peloton Interactive PTON +32% Amazon buying Peloton would give it several benefits, including Prime boost: Truist. IceCure Medical (NASDAQ:ICCM) +17%. Origin Agritech (NASDAQ:SEED) +15% issues 2022 guidance of 300% revenue growth. Spirit Airlines SAVE +11% on Q4 results. H...

IMMX - 5 Short-Squeeze Candidates to Watch Today: IMMX, ALTM, GLTB, CRTX and TSRI

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-squeeze stocks continue to be hot with traders and we’re going over five candidates that investors will want to watch today. Source: Alextype/Shutterstock.com Today’s list of short-squeeze candid...
Previous 10 Next 10